Coenzyme Q, peroxidation and cytochrome oxidase features after Parkinson's-like disease by MPTP toxicity in intra-synaptic and non-synaptic mitochondria fromMacaca Fascicularis cerebral cortex and hippocampus: action of dihydroergocriptine-Reference-Cited by-同舟云学术

Coenzyme Q, peroxidation and cytochrome oxidase features after Parkinson's-like disease by MPTP toxicity in intra-synaptic and non-synaptic mitochondria fromMacaca Fascicularis cerebral cortex and hippocampus: action of dihydroergocriptine

Published:1996-12 Issue:12 Volume:21 Page:1505-1514
ISSN:0364-3190
Container-title:Neurochemical Research
language:en
Short-container-title:Neurochem Res

Author:

Battino M.,Littarru G. P.,Gorini A.,Villa R. F.

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,General Medicine,Biochemistry

Link

http://link.springer.com/content/pdf/10.1007/BF02533098.pdf

Reference60 articles.

1. Mizuno, Y., Ikebe, S., Hattori, N., Kondo, T., Tanaka, M., and Ozawa, T. 1993. Mitochondrial energy crisis in Parkinson's disease. Adv. Neurol. 60:282–287.

2. Schapira, A.H.V. 1993. Mitochondrial complex I deficiency in Parkinson's disease. Adv. Neurol. 60:288–291.

3. Reichmann, H., Lestienne, P., Jellinger, K., and Riederer, P. 1993. Parkinson's disease and the electron transport chain in postmortem brain. Adv. Neurol., 60:297–299.

4. Schapira, A.H.V., Cooper, J.M., Dexter, D., Clark, J.B., Jenner, P., and Marsden, C.D. 1990. Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54:823:827.

5. Langston, J.W., Ballard, P., Tetrud, J.W., and Irwin, I. 1983. Chronic parkinsonism in humans due to a product of meperidineanalog synthesis. Science 219:979–980.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study of molecular patterns associated with ferroptosis in Parkinson’s disease and its immune signature;PLOS ONE;2023-12-21

2. Research progress in the molecular mechanism of ferroptosis in Parkinson's disease and regulation by natural plant products;Ageing Research Reviews;2023-11

3. Impact Factor of Vitamin K on Parkinson’s Disease;Advances in Clinical Medicine;2023

4. Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson’s disease;Frontiers in Pharmacology;2022-09-12

5. Alpha synuclein determines ferroptosis sensitivity in dopaminergic neurons via modulation of ether-phospholipid membrane composition;Cell Reports;2022-08